Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Patient Protection and Affordable Care Act | 14 | 2024 | 1187 | 3.510 |
Why?
|
Medicare Part D | 12 | 2024 | 349 | 2.700 |
Why?
|
Medicaid | 12 | 2024 | 2793 | 2.110 |
Why?
|
Cost Sharing | 11 | 2023 | 405 | 1.920 |
Why?
|
Medicare | 14 | 2023 | 6689 | 1.380 |
Why?
|
Insurance Coverage | 14 | 2023 | 1929 | 1.340 |
Why?
|
Mental Health Services | 6 | 2024 | 1696 | 1.200 |
Why?
|
Health Services Accessibility | 10 | 2024 | 5280 | 1.040 |
Why?
|
Prescription Drugs | 3 | 2024 | 623 | 0.960 |
Why?
|
Patient Acceptance of Health Care | 8 | 2024 | 3117 | 0.950 |
Why?
|
Insurance, Health | 12 | 2023 | 2490 | 0.920 |
Why?
|
California | 13 | 2023 | 1395 | 0.900 |
Why?
|
Medically Uninsured | 5 | 2022 | 837 | 0.830 |
Why?
|
Fitness Centers | 1 | 2022 | 13 | 0.820 |
Why?
|
Financing, Personal | 6 | 2020 | 309 | 0.810 |
Why?
|
Community Health Centers | 4 | 2021 | 442 | 0.810 |
Why?
|
Deductibles and Coinsurance | 4 | 2020 | 316 | 0.760 |
Why?
|
Health Expenditures | 5 | 2018 | 2334 | 0.760 |
Why?
|
United States | 53 | 2024 | 71434 | 0.750 |
Why?
|
Taxes | 2 | 2022 | 219 | 0.730 |
Why?
|
Insurance Selection Bias | 2 | 2018 | 69 | 0.700 |
Why?
|
Nurse Practitioners | 1 | 2022 | 266 | 0.650 |
Why?
|
Bipolar Disorder | 6 | 2024 | 5069 | 0.640 |
Why?
|
Fees and Charges | 1 | 2019 | 191 | 0.620 |
Why?
|
Drugs, Generic | 2 | 2016 | 444 | 0.580 |
Why?
|
National Health Programs | 1 | 2020 | 443 | 0.580 |
Why?
|
Polypharmacy | 1 | 2019 | 305 | 0.550 |
Why?
|
Insurance Benefits | 3 | 2020 | 183 | 0.550 |
Why?
|
Antipsychotic Agents | 4 | 2024 | 3049 | 0.540 |
Why?
|
Gender Identity | 1 | 2022 | 694 | 0.540 |
Why?
|
Anti-Asthmatic Agents | 5 | 2017 | 559 | 0.510 |
Why?
|
Health Facilities | 1 | 2020 | 571 | 0.510 |
Why?
|
Mental Disorders | 3 | 2024 | 6694 | 0.500 |
Why?
|
Vaccines | 1 | 2024 | 830 | 0.500 |
Why?
|
Physicians, Primary Care | 1 | 2021 | 610 | 0.480 |
Why?
|
Patient Compliance | 3 | 2018 | 2680 | 0.460 |
Why?
|
Electronic Mail | 1 | 2015 | 208 | 0.460 |
Why?
|
Poverty | 5 | 2022 | 2638 | 0.460 |
Why?
|
Medication Adherence | 4 | 2019 | 2133 | 0.460 |
Why?
|
Massachusetts | 9 | 2024 | 8706 | 0.450 |
Why?
|
Asthma | 9 | 2017 | 6144 | 0.450 |
Why?
|
Risperidone | 1 | 2016 | 380 | 0.440 |
Why?
|
Income | 5 | 2020 | 1864 | 0.430 |
Why?
|
Psychiatry | 2 | 2022 | 1691 | 0.420 |
Why?
|
Influenza, Human | 1 | 2024 | 1528 | 0.420 |
Why?
|
Mental Health | 3 | 2023 | 3150 | 0.410 |
Why?
|
Models, Economic | 1 | 2015 | 714 | 0.390 |
Why?
|
Leukotriene Antagonists | 4 | 2016 | 123 | 0.390 |
Why?
|
Adrenal Cortex Hormones | 5 | 2016 | 1868 | 0.370 |
Why?
|
Drug Costs | 5 | 2013 | 1176 | 0.360 |
Why?
|
Fees, Pharmaceutical | 1 | 2009 | 66 | 0.350 |
Why?
|
Humans | 80 | 2024 | 752810 | 0.330 |
Why?
|
Medically Underserved Area | 2 | 2022 | 258 | 0.330 |
Why?
|
Child Health Services | 1 | 2014 | 653 | 0.320 |
Why?
|
Anxiety Disorders | 1 | 2019 | 2687 | 0.300 |
Why?
|
Primary Health Care | 4 | 2021 | 4617 | 0.300 |
Why?
|
Male | 52 | 2024 | 355160 | 0.300 |
Why?
|
Female | 53 | 2024 | 386339 | 0.290 |
Why?
|
Schizophrenia | 3 | 2022 | 6879 | 0.280 |
Why?
|
Office Visits | 4 | 2017 | 591 | 0.280 |
Why?
|
Tobacco Smoke Pollution | 2 | 2023 | 809 | 0.280 |
Why?
|
Substance-Related Disorders | 1 | 2023 | 4320 | 0.270 |
Why?
|
Minority Groups | 2 | 2024 | 1194 | 0.260 |
Why?
|
Comparative Effectiveness Research | 1 | 2011 | 704 | 0.250 |
Why?
|
Smoking Cessation | 3 | 2022 | 2077 | 0.250 |
Why?
|
Aged | 28 | 2024 | 166705 | 0.250 |
Why?
|
Health Services Needs and Demand | 1 | 2013 | 1392 | 0.250 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 3307 | 0.250 |
Why?
|
Adrenergic beta-Agonists | 3 | 2016 | 347 | 0.250 |
Why?
|
Reimbursement Mechanisms | 1 | 2009 | 662 | 0.230 |
Why?
|
Cohort Studies | 11 | 2024 | 40996 | 0.230 |
Why?
|
Adult | 31 | 2024 | 217168 | 0.230 |
Why?
|
Ambulatory Care Facilities | 2 | 2020 | 917 | 0.220 |
Why?
|
Group Homes | 1 | 2023 | 58 | 0.220 |
Why?
|
Quality Indicators, Health Care | 2 | 2010 | 1810 | 0.210 |
Why?
|
Depressive Disorder, Major | 1 | 2020 | 4691 | 0.210 |
Why?
|
Quality Assurance, Health Care | 2 | 2010 | 2171 | 0.210 |
Why?
|
Criminals | 1 | 2023 | 64 | 0.200 |
Why?
|
Atherosclerosis | 1 | 2018 | 3502 | 0.200 |
Why?
|
Lithium | 2 | 2022 | 598 | 0.200 |
Why?
|
Tobacco Use Cessation | 1 | 2022 | 94 | 0.190 |
Why?
|
Housing | 3 | 2023 | 656 | 0.190 |
Why?
|
Food Supply | 2 | 2024 | 520 | 0.180 |
Why?
|
Young Adult | 11 | 2024 | 57732 | 0.180 |
Why?
|
Clinical Trials as Topic | 2 | 2023 | 7997 | 0.180 |
Why?
|
Middle Aged | 22 | 2024 | 217250 | 0.170 |
Why?
|
Health Benefit Plans, Employee | 3 | 2012 | 334 | 0.170 |
Why?
|
Immunization | 1 | 2024 | 1219 | 0.170 |
Why?
|
Adolescent | 15 | 2024 | 86822 | 0.170 |
Why?
|
Insurance, Medigap | 2 | 2009 | 21 | 0.170 |
Why?
|
Eligibility Determination | 1 | 2022 | 405 | 0.160 |
Why?
|
Prediabetic State | 1 | 2024 | 529 | 0.160 |
Why?
|
Cross-Sectional Studies | 11 | 2024 | 25540 | 0.150 |
Why?
|
Psychotic Disorders | 2 | 2024 | 3137 | 0.150 |
Why?
|
Risk Adjustment | 3 | 2011 | 598 | 0.150 |
Why?
|
Conversion Disorder | 1 | 2021 | 203 | 0.150 |
Why?
|
Clinical Competence | 2 | 2010 | 4713 | 0.150 |
Why?
|
Chlorofluorocarbons | 1 | 2016 | 12 | 0.140 |
Why?
|
Diabetes Mellitus | 3 | 2010 | 5840 | 0.140 |
Why?
|
Tobacco Use Disorder | 1 | 2022 | 696 | 0.140 |
Why?
|
Emergency Service, Hospital | 6 | 2024 | 7730 | 0.140 |
Why?
|
Costs and Cost Analysis | 3 | 2022 | 1674 | 0.140 |
Why?
|
State Health Plans | 1 | 2018 | 220 | 0.130 |
Why?
|
Fee-for-Service Plans | 1 | 2021 | 697 | 0.130 |
Why?
|
Nursing Homes | 1 | 2023 | 1061 | 0.130 |
Why?
|
Nebulizers and Vaporizers | 1 | 2016 | 136 | 0.130 |
Why?
|
Albuterol | 1 | 2016 | 211 | 0.130 |
Why?
|
Socioeconomic Factors | 5 | 2018 | 7746 | 0.130 |
Why?
|
Logistic Models | 7 | 2024 | 13277 | 0.120 |
Why?
|
Hypertension | 3 | 2022 | 8497 | 0.120 |
Why?
|
Physicians, Family | 1 | 2017 | 351 | 0.120 |
Why?
|
Vulnerable Populations | 1 | 2020 | 694 | 0.120 |
Why?
|
Insurance, Pharmaceutical Services | 2 | 2009 | 345 | 0.120 |
Why?
|
Professional Practice | 1 | 2016 | 311 | 0.110 |
Why?
|
Managed Care Programs | 2 | 2009 | 935 | 0.110 |
Why?
|
Administration, Inhalation | 3 | 2015 | 1147 | 0.110 |
Why?
|
Parents | 3 | 2017 | 3497 | 0.110 |
Why?
|
Emergency Services, Psychiatric | 1 | 2013 | 69 | 0.110 |
Why?
|
Pandemics | 2 | 2023 | 8499 | 0.110 |
Why?
|
Drug Labeling | 1 | 2015 | 247 | 0.100 |
Why?
|
Data Collection | 1 | 2022 | 3302 | 0.100 |
Why?
|
Medical Savings Accounts | 1 | 2012 | 34 | 0.100 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2012 | 3933 | 0.100 |
Why?
|
Interviews as Topic | 4 | 2013 | 2619 | 0.100 |
Why?
|
Sexual Behavior | 1 | 2022 | 2062 | 0.100 |
Why?
|
Telephone | 1 | 2015 | 623 | 0.100 |
Why?
|
Anticonvulsants | 1 | 2022 | 1881 | 0.100 |
Why?
|
American Recovery and Reinvestment Act | 1 | 2012 | 71 | 0.100 |
Why?
|
Drug Prescriptions | 2 | 2015 | 1657 | 0.100 |
Why?
|
Antidepressive Agents | 1 | 2024 | 2871 | 0.100 |
Why?
|
Vaccination | 1 | 2024 | 3321 | 0.100 |
Why?
|
Competitive Medical Plans | 1 | 2011 | 26 | 0.100 |
Why?
|
Health Services Research | 1 | 2019 | 1809 | 0.100 |
Why?
|
Child | 11 | 2023 | 78996 | 0.100 |
Why?
|
Public Housing | 2 | 2023 | 140 | 0.100 |
Why?
|
Blood Pressure | 1 | 2007 | 8468 | 0.100 |
Why?
|
Suicide, Attempted | 2 | 2020 | 1242 | 0.090 |
Why?
|
Health Planning | 1 | 2012 | 234 | 0.090 |
Why?
|
Hyperlipidemias | 2 | 2013 | 782 | 0.090 |
Why?
|
Drug Utilization | 2 | 2008 | 1192 | 0.090 |
Why?
|
Medicare Part C | 1 | 2016 | 307 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1625 | 0.090 |
Why?
|
Child, Preschool | 9 | 2021 | 41656 | 0.090 |
Why?
|
Workload | 1 | 2016 | 838 | 0.090 |
Why?
|
Aged, 80 and over | 10 | 2013 | 58347 | 0.090 |
Why?
|
Diet | 3 | 2024 | 7950 | 0.090 |
Why?
|
Health Policy | 2 | 2022 | 2655 | 0.090 |
Why?
|
Documentation | 1 | 2016 | 879 | 0.090 |
Why?
|
Quality of Health Care | 1 | 2024 | 4343 | 0.080 |
Why?
|
Educational Measurement | 1 | 2016 | 1244 | 0.080 |
Why?
|
Telemedicine | 1 | 2006 | 2947 | 0.080 |
Why?
|
Health Care Costs | 4 | 2021 | 3209 | 0.080 |
Why?
|
Self Report | 1 | 2019 | 3649 | 0.080 |
Why?
|
Preventive Health Services | 1 | 2012 | 569 | 0.070 |
Why?
|
Adrenergic Antagonists | 1 | 2007 | 26 | 0.070 |
Why?
|
Thiazides | 1 | 2007 | 19 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2019 | 1773 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2013 | 2937 | 0.070 |
Why?
|
Mammography | 2 | 2016 | 2434 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2023 | 3302 | 0.070 |
Why?
|
Comorbidity | 2 | 2019 | 10475 | 0.070 |
Why?
|
Choice Behavior | 1 | 2012 | 809 | 0.070 |
Why?
|
Research Design | 1 | 2022 | 6118 | 0.070 |
Why?
|
Health Maintenance Organizations | 3 | 2016 | 658 | 0.070 |
Why?
|
Personal Health Services | 1 | 2005 | 24 | 0.070 |
Why?
|
Health Status | 2 | 2015 | 4050 | 0.060 |
Why?
|
Health Care Reform | 1 | 2014 | 1242 | 0.060 |
Why?
|
Information Services | 1 | 2006 | 236 | 0.060 |
Why?
|
General Surgery | 1 | 2016 | 1642 | 0.060 |
Why?
|
Pharmaceutical Services | 1 | 2006 | 141 | 0.060 |
Why?
|
Physician-Patient Relations | 2 | 2010 | 3202 | 0.060 |
Why?
|
Drug Therapy, Combination | 2 | 2022 | 6482 | 0.060 |
Why?
|
Health Status Indicators | 1 | 2010 | 968 | 0.060 |
Why?
|
Attitude to Computers | 1 | 2005 | 196 | 0.060 |
Why?
|
Diuretics | 1 | 2007 | 611 | 0.060 |
Why?
|
Medical Informatics Applications | 1 | 2005 | 179 | 0.050 |
Why?
|
Hospitalization | 4 | 2021 | 10628 | 0.050 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2012 | 922 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10200 | 0.050 |
Why?
|
Longitudinal Studies | 4 | 2023 | 14323 | 0.050 |
Why?
|
Appointments and Schedules | 1 | 2006 | 429 | 0.050 |
Why?
|
Patient Satisfaction | 3 | 2017 | 3427 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2019 | 64288 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3163 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2023 | 79160 | 0.050 |
Why?
|
Sex Distribution | 1 | 2006 | 2290 | 0.050 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2022 | 6001 | 0.050 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12138 | 0.050 |
Why?
|
Chronic Disease | 1 | 2015 | 9174 | 0.050 |
Why?
|
Age Distribution | 1 | 2006 | 2882 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 12154 | 0.040 |
Why?
|
Communication | 3 | 2010 | 3818 | 0.040 |
Why?
|
Odds Ratio | 2 | 2013 | 9701 | 0.040 |
Why?
|
Valproic Acid | 1 | 2022 | 444 | 0.040 |
Why?
|
Early Diagnosis | 1 | 2024 | 1178 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7407 | 0.040 |
Why?
|
Cost of Illness | 1 | 2008 | 1911 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2007 | 6245 | 0.040 |
Why?
|
Policy | 1 | 2022 | 505 | 0.040 |
Why?
|
Antimanic Agents | 1 | 2022 | 520 | 0.040 |
Why?
|
Soil | 1 | 2016 | 110 | 0.030 |
Why?
|
Internship and Residency | 1 | 2016 | 5810 | 0.030 |
Why?
|
Medication Reconciliation | 1 | 2017 | 151 | 0.030 |
Why?
|
Depression | 1 | 2015 | 7920 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2008 | 5481 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2010 | 19907 | 0.030 |
Why?
|
Psychotherapy | 1 | 2024 | 1627 | 0.030 |
Why?
|
Ambulatory Care | 2 | 2021 | 2743 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2021 | 1699 | 0.030 |
Why?
|
Health Care Surveys | 2 | 2012 | 2427 | 0.030 |
Why?
|
Databases, Factual | 2 | 2024 | 7899 | 0.030 |
Why?
|
Insurance Claim Review | 1 | 2016 | 735 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2015 | 25910 | 0.020 |
Why?
|
Economic Recession | 1 | 2012 | 79 | 0.020 |
Why?
|
Risk Factors | 1 | 2018 | 73418 | 0.020 |
Why?
|
Qualitative Research | 1 | 2021 | 2886 | 0.020 |
Why?
|
Unemployment | 1 | 2012 | 210 | 0.020 |
Why?
|
Consumer Health Information | 1 | 2012 | 209 | 0.020 |
Why?
|
Infant | 2 | 2015 | 35673 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2560 | 0.020 |
Why?
|
Health Surveys | 1 | 2019 | 4014 | 0.020 |
Why?
|
Financing, Government | 1 | 2012 | 466 | 0.020 |
Why?
|
Hospitals, University | 1 | 2010 | 569 | 0.020 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2011 | 382 | 0.020 |
Why?
|
New York City | 1 | 2010 | 712 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2015 | 1665 | 0.020 |
Why?
|
Propensity Score | 1 | 2013 | 1872 | 0.020 |
Why?
|
Smoking | 1 | 2022 | 9029 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5277 | 0.020 |
Why?
|
Administration, Oral | 1 | 2013 | 4002 | 0.020 |
Why?
|
Poisson Distribution | 1 | 2006 | 507 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5395 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2011 | 2353 | 0.020 |
Why?
|
Educational Status | 1 | 2012 | 2498 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 2321 | 0.010 |
Why?
|
Health Personnel | 1 | 2016 | 3270 | 0.010 |
Why?
|
Computers | 1 | 2005 | 595 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15695 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9613 | 0.010 |
Why?
|
Hypolipidemic Agents | 1 | 2006 | 621 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15505 | 0.010 |
Why?
|
Linear Models | 1 | 2010 | 5858 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2010 | 2274 | 0.010 |
Why?
|
Disease Progression | 1 | 2013 | 13403 | 0.010 |
Why?
|
Regression Analysis | 1 | 2006 | 6363 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2006 | 2037 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2010 | 5370 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 21857 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2006 | 3108 | 0.010 |
Why?
|
Algorithms | 1 | 2010 | 13905 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2016 | 20844 | 0.000 |
Why?
|
Concepts
(251)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(52)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_